These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 131730)
1. Antitumor effect of protein-bound polysaccharide preparation, PS-K, against 3-methylcholanthrene-induced fibrosarcoma in C57BL/6 mice. Ohno R; Imai K; Yokomaku S; Yamada K Gan; 1975 Dec; 66(6):679-81. PubMed ID: 131730 [TBL] [Abstract][Full Text] [Related]
2. Mouse strain difference in the expression of antitumor activity of PS-K. Yoshikumi C; Nomoto K; Matsunaga K; Fuji T; Takeya K Gan; 1975 Dec; 66(6):649-54. PubMed ID: 131729 [TBL] [Abstract][Full Text] [Related]
3. Correlation of differences in antigenicity of four 3-methyl-cholanthrene-induced tumors in syngeneic mice with the susceptibility of tumors to an immunopotentiator, PS-K. Abe S; Yamazaki M; Mizuno D Gan; 1978 Apr; 69(2):223-8. PubMed ID: 680462 [TBL] [Abstract][Full Text] [Related]
4. Immunochemotherapy of transplanted KMT-17 tumor in WKA rats by combination of cyclophosphamide and immunostimulatory protein-bound polysaccharide isolated from basidiomycetes. Akiyama J; Kawamura T; Gotohda E; Yamada Y; Hosokawa M; Kodama T; Kobayashi H Cancer Res; 1977 Sep; 37(9):3042-5. PubMed ID: 884662 [TBL] [Abstract][Full Text] [Related]
5. Antitumor effect of PSK at a distant site: tumor-specific immunity and combination with other chemotherapeutic agents. Ebina T; Murata K Jpn J Cancer Res; 1992 Jul; 83(7):775-82. PubMed ID: 1517151 [TBL] [Abstract][Full Text] [Related]
6. Antitumor effect of polysaccharide TC-13 on allogeneic and syngeneic tumors in mice. Kohno M; Abe S; Yamazaki M; Mizuno D Gan; 1982 Jun; 73(3):488-94. PubMed ID: 7129013 [TBL] [Abstract][Full Text] [Related]
7. Autoreactive and heat shock protein 60-recognizing CD4+ T-cells show antitumor activity against syngeneic fibrosarcoma. Harada M; Matsuzaki G; Yoshikai Y; Kobayashi N; Kurosawa S; Takimoto H; Nomoto K Cancer Res; 1993 Jan; 53(1):106-11. PubMed ID: 8093229 [TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methylcholanthrene-induced carcinogenesis. Suga T; Shiio T; Maeda YY; Chihara G Cancer Res; 1984 Nov; 44(11):5132-7. PubMed ID: 6488173 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects of PS-K and busulfan on the recurrent and metastatic diseases after the surgical removal of 3-methylcholanthrene-induced autochthonous tumors in C57BL/6 mice. Hosokawa M; Mizukoshi T; Sugawara M; Kobayashi H Jpn J Cancer Res; 1985 Jan; 76(1):61-7. PubMed ID: 3918911 [TBL] [Abstract][Full Text] [Related]
10. Comparative immunotherapeutic effect of concanavalin A and neuraminidase-treated cancer cells. Simmons RL; Rios A Transplant Proc; 1975 Jun; 7(2):247-51. PubMed ID: 1129845 [No Abstract] [Full Text] [Related]
11. Antitumor activity of astaxanthin and its mode of action. Jyonouchi H; Sun S; Iijima K; Gross MD Nutr Cancer; 2000; 36(1):59-65. PubMed ID: 10798217 [TBL] [Abstract][Full Text] [Related]
12. Antitumor effect of interferon preparations of murine transplantable tumors. Takeyama H; Kawashima K; Kobayashi M; Yamada K; Ito Y Gan; 1978 Oct; 69(5):641-7. PubMed ID: 729962 [No Abstract] [Full Text] [Related]
13. Effect of PS-K, a protein polysaccharide, on pulmonary metastases of a C3H mouse squamous cell carcinoma. Usui S; Urano M; Koike S; Kobayashi Y J Natl Cancer Inst; 1976 Jan; 56(1):185-7. PubMed ID: 130494 [TBL] [Abstract][Full Text] [Related]
14. Induction of antitumor immunity by tumor cells treated with abrin. Shionoya H; Arai H; Koyanagi N; Ohtake S; Kobayashi H; Kodama T; Kato H; Tung TC; Lin JY Cancer Res; 1982 Jul; 42(7):2872-6. PubMed ID: 7083176 [TBL] [Abstract][Full Text] [Related]
15. Antitumor effect of echitamine chloride on methylcholonthrene induced fibrosarcoma in rats. Kamarajan P; Sekar N; Mathuram V; Govindasamy S Biochem Int; 1991 Oct; 25(3):491-8. PubMed ID: 1805793 [TBL] [Abstract][Full Text] [Related]
16. Cyclophosphamide-induced changes in the cellular composition of a methylcholanthrene-induced tumor and their relation to bone marrow and blood leukocyte levels. Evans R; Madison LD; Eidlen DM Cancer Res; 1980 Feb; 40(2):395-402. PubMed ID: 7356522 [No Abstract] [Full Text] [Related]
18. Sialylation of 3-methylcholanthrene-induced fibrosarcoma determines antitumor immune responses during immunoediting. Cohen M; Elkabets M; Perlmutter M; Porgador A; Voronov E; Apte RN; Lichtenstein RG J Immunol; 2010 Nov; 185(10):5869-78. PubMed ID: 20956342 [TBL] [Abstract][Full Text] [Related]
19. The therapeutic effects of an immunopotentiator, PS-K, on 3-methylcholanthrene-induced autochthonous tumors in C57BL/6 mice in combination with the surgical removal of primary sites. Hosokawa M; Mizukoshi T; Morikawa K; Xu ZY; Kobayashi H Cancer Immunol Immunother; 1986; 22(3):181-5. PubMed ID: 3731203 [TBL] [Abstract][Full Text] [Related]
20. Combination of active and passive immunization and chemotherapy to transplantation of methylcholanthrene-induced tumor in WKA rats. Gotoda E; Sendo F; Hosokawa M; Kodama T; Kobayashi H Cancer Res; 1974 Aug; 34(8):1947-51. PubMed ID: 4842248 [No Abstract] [Full Text] [Related] [Next] [New Search]